Key facts
- It has raised $1.0M; the latest was Early Stage VC ($820K) in Apr 2025.
- Notable investors include Berkeley SkyDeck, SBXi, FFG Venture Business Partners, Keio Innovation Initiative, Formic Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for One Genomics
- ·The full record, as it builds
Funding rounds
No funding rounds for One Genomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About One Genomics
Developer of genomic analysis software designed to automate the processing of complex sequencing data for clinical and research purposes. The company's platform offers automated variant calling, cloud storage, and clinical reporting tools, enabling diagnostic labs to accelerate research results through standardized data interpretation.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 5
- Website
- onegenomics.co/
- Ownership
- Privately Held (backing)
One Genomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in One Genomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on One Genomics in its N-PORT filings yet. We sweep new filings monthly.